Invention Grant
- Patent Title: Kinase inhibitors
-
Application No.: US14537980Application Date: 2014-11-11
-
Publication No.: US09636340B2Publication Date: 2017-05-02
- Inventor: Ayyappan K. Rajasekaran
- Applicant: Ayyappan K. Rajasekaran
- Applicant Address: US PA Glen Mills
- Assignee: Ayyappan K. Rajasekaran
- Current Assignee: Ayyappan K. Rajasekaran
- Current Assignee Address: US PA Glen Mills
- Agency: Paul & Paul
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K31/4741 ; A61K47/48
Abstract:
The disclosed molecules are inhibitors of Bcr-Abl and Src kinases. The molecules are cytotoxic to Gleevec resistant cells. Inhibitors of Bcr-Abl and Src kinases are used in the treatment of Chronic Myelogenous Leukemia among other diseases.
Public/Granted literature
- US20150140071A1 KINASE INHIBITORS Public/Granted day:2015-05-21
Information query
